Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia. 2012

Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
Transfusion Medicine Department, Institute for Mother and Child Health Care of Serbia Dr Vukan Cupic, Radoja Dakica 6-8, 11 070 Belgrade, Serbia. imdtransfuzija@yahoo.com

Complications caused by elevated white blood cell count in pediatric patients with CML could be a presenting feature of the disease. Here, we present two adolescents, aged 16 and 17years, who were admitted for investigation of extremely elevated leukocytes and complications of leucostasis. Initial manifestations were priapism and blurred vision, respectively. Diagnosis of chronic phase of chronic myeloid leukemia is established, and conventional measures for leucoreduction began. However, since there were no improvements, a leukapheresis procedure was initiated. After undergoing 3 daily procedures the leukocyte count declined for each patient, with resolution of pripaism and ophtalmological disturbances. Leukapheresis is safe and effective therapeutic option for patients with complications of hyperleucocytosis. If started in a timely manner, permanent organ damage or death could be avoided.

UI MeSH Term Description Entries
D007937 Leukapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Leukocytapheresis,Leukopheresis,Lymphapheresis,Lymphocytapheresis,Leukocytopheresis,Lymphocytopheresis,Lymphopheresis,Leukaphereses,Leukocytaphereses,Leukocytophereses,Leukophereses,Lymphaphereses,Lymphocytaphereses,Lymphocytophereses,Lymphophereses
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D018921 Leukostasis Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs. Leukostasis Syndrome,Leukostases,Leukostasis Syndromes,Syndrome, Leukostasis,Syndromes, Leukostasis

Related Publications

Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
December 2001, Nihon rinsho. Japanese journal of clinical medicine,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
May 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
November 1991, American journal of hematology,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
December 1973, Blood,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
May 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
January 1982, Transfusion,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
June 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
June 1986, American journal of hematology,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
January 2011, Journal of clinical apheresis,
Dobrila Veljković, and Milos Kuzmanović, and Dragan Mićić, and Olivera Šerbić-Nonković
August 1973, Minnesota medicine,
Copied contents to your clipboard!